| Application no. and date | 03766212.9 (espacenet) (Federated) (European Patent Register), 20030718 | | Patent/reg. no. and date | DK/EP 1527047, 20120328 | | Publication date | 20050504 | | Priority no. and date | DE 10233500, 20020724 | | EP pub. no. and date |
EP 1527047 20050504 | | Effective date | | | Applicant/owner | Boehringer Ingelheim Pharma GmbH & Co. KG,
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 156633 | | Inventor | RALL, Werner, Beethovenstrasse 33
88441 Mittelbiberach, DE,
BOCK, Thomas, Soeren Norbys Allee 5-1, 2300 København S, DK,
HILBERG, Frank, Pilgramgasse 18/22
A-1050 Wien, AT,
ROTH, Gerald, Jürgen, Akazienweg 47
88400 Biberach, DE,
SIEGER, Peter, Wielandstrasse 27
88441 Mittelbiberach, DE,
LINZ, Guenter, Eschenweg 6
88441 Mittelbiberach, DE | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/404 (2006.01) , A61P 35/04 (2006.01) , C07D 209/34 (2006.01) | | Title | 3-Z-[1-(4-(N-((4-methyl-piperazin-1-yl)-methylcarbonyl)-N-methyl-amin)-anilino)-1-phenyl-methylen]-6-methoxycarbonyl-2-indolinon-monoethansulphonat og anvendelse deraf som en farmaceutisk sammensætning | | Int. application no. | EP2003007822 | | Int. publication no. | WO2004013099 | | Related patent (certificate) | | | Status | Udløbet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
